// App-Quantinova.ai

: A Systematic Literature Review (SLR) of Clinical Outcomes after Stem Cell Transplantation (SCT) in Adult Acute Lymphoblastic Leukemia (ALL) Patients with or without Minimal Residual Disease (MRD)

Researchers

Presenter

  • Monica Turner

Principal Investigators

  • Shweta Shah

  • Amber Martin

  • Ze Cong

  • Anthony S. Stein

Medical Centers

  • Evidera, Waltham, MA

  • Amgen Inc, Thousand Oaks, CA

  • Global Health Economics, Amgen Inc., South San Francisco, CA

  • Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope, Duarte, CA

Locations

  • United States

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A